Flash pulmonary oedema following arteriovenous fistula surgery: rapid assessment and treatment is key to break the vicious cycle
- Jagadeep Ajmera ,
- Manjunath Maruti Pol ,
- Belmin Winston Gysley and
- Bhanupradeep Yadav
- Department of Surgical Disciplines, AIIMS, New Delhi, India
- Correspondence to Dr Manjunath Maruti Pol; manjunath.pol@gmail.com
Abstract
An early adolescent boy with chronic kidney disease on haemodialysis was referred to the surgical clinic for the creation of an arteriovenous fistula. He was undergoing treatment for dilated cardiomyopathy and extrapulmonary tuberculosis. The patient was haemodynamically stable during the procedure, but he developed rapidly progressing dyspnoea, tachycardia and tachypnoea about 10 min after the vessels were declamped. His blood pressure rapidly rose above 220/120 mm Hg and saturation dropped below 90%. A multidisciplinary team (MDT) constituted of surgeons, nephrologists and intensivists was quickly activated. The patient was put on a mechanical ventilator and resuscitated with parenteral antihypertensives, diuretics, amiodarone and haemodialysis. The patient improved clinically and was discharged on the third postoperative day. Thus, a rapidly activated MDT approach was key in breaking the vicious cycle caused by hypertensive crisis, myocardial dysfunction and impending ventilatory failurethat occurred following access surgery.
Background
Flash pulmonary oedema (FPE) is a life-threatening clinical condition that causes acute respiratory distress. It is characterised by the development of acute dyspnoea due to the rapid accumulation of fluid in the interstitial and alveolar spaces of the lungs. FPE is a common term used to describe the dramatic form of acute decompensated heart failure.1 The prevalence of heart failure is around 40% in patients with chronic kidney disease.2 FPE can occur in any condition that disrupts pulmonary fluid homeostasis, for example, excessive activation of the renin–angiotensin system.3
In the literature, there are many cases of FPE caused by a variety of reasons, but to our knowledge, this is the first case of FPE that occurred immediately following the creation of an arteriovenous fistula (AVF) in a patient with prior heart disease. This study emphasises the importance of a multidisciplinary team (MDT) approach instituted immediately to break the vicious cycle of hypertensive crisis, myocardial dysfunction and impending ventilatory failure.
Case presentation
An early adolescent boy with a known case of end-stage kidney disease had been on haemodialysis (HD) for 4 months and was referred to the surgery clinic for the creation of an AVF. His medical history revealed that he was taking medicines for hypertension, dilated cardiomyopathy with systolic dysfunction and extrapulmonary tuberculosis. He has been undergoing maintenance HD through the right internal jugular vein catheter since 4 months. Prior to the surgery, the patient’s haemoglobin was 85 g/L, whole blood cell count was 8.7×109/L and platelets were 230×109 /L. His blood urea was 108 g/dL, and his serum creatinine was 8 g/dL, his serum sodium was 146 mmol/L and his potassium was 5 mmol/L. The patients’ ECG showed a strain pattern with left ventricular hypertrophy. His echocardiogram showed dilated cardiomyopathy, left ventricular hypertrophy, an ejection fraction of 30% and moderate systolic dysfunction. His chest X-ray showed minimal pleural effusion on the right side. He had undergone HD 2 days prior to vascular access surgery. His preoperative haemodynamics showed a heart rate of 88 beats per minute; blood pressure was 140/80 mm Hg; respiratory rate was 18 breaths per minute and saturation was 99% on room air. The left Brachio-Cephalic AVF was performed under local anaesthesia and was completed in 55 min. The patient was stable throughout the procedure, and the AVF was functioning with a good thrill after declamping the vessels. About 10 min after completing the procedure, the patient began having cough and dyspnoea in the supine position. His heart rate was 110 bpm, blood pressure was 188/96 mm Hg, respiratory rate was 24; Spo2 was 93% on room air and 99% on face mask 4 L/min. Immediately, a team of intensivists and nephrologists were informed. About 20 min following surgery, the patient had progressive desaturation from Spo2 of 99% on 4 L/m oxygen to 88% on 10 L/min oxygen in the postsurgery recovery room. His haemodynamic parameters at the end of 60 min following surgery showed a heart rate of 122 beats per minute, blood pressure of 220/136 mm Hg, a respiratory rate of 40 breaths/min and Spo2: 88% on 15 L/min oxygen by non-rebreathing mask (NRBM). On auscultation, the patient had crepitation on bilateral chest examination. A provisional diagnosis of acute PE with accelerated hypertension was made.
Investigations
Arterial blood gas analysis showed respiratory acidosis (figure 1), and his Chest X-ray showed massive PE in bilateral lung fields (figure 2). His ECG showed strain pattern with left ventricular hypertrophy, no ST elevation (figure 3).
Arterial blood gas analysis showing respiratory acidosis.
ECG showing strain pattern with left ventricular hypertrophy, no ST elevation(V1-V6 are chest leads; aVR, aVL, aVF are augented leads; I,II,III are limb leads).
Immediate postoperative chest X-ray showing bilateral pulmonary oedema.
Differential diagnosis
Sudden fall of saturation made us keep acute myocardial infarction and pulmonary embolism as differentials. But on evaluating further no ST changes were seen on ECG. Cardiac markers troponin I and T were normal. Bedside echocardiogram was also done which revealed no embolus.
Treatment
An MDT approach was used, and management included ongoing assessment and treatment to maintain airway, breathing, circulation, neurological disability and hypothermia prevention. Initially, the patient was put on a non-invasive ventilator (NIV) machine as he was not maintaining saturation on NRBM (oxygen flow rate of 15 L/min). He was administered injection esmolol 4 mg, injection lasix 40 mg and injection diltiazem 10 mg to normalise his blood pressure. His haemodynamic parameters at the end of one and a half hours were: heart rate of 118 bpm; blood pressure was 180/96 mm Hg; respiratory rate was 35 breaths per minute and saturation was 93% on NIV. Subsequently, injection nitroglycerin 50 mg/10 mL 1 mL/hour was started. As the patient began desaturating on NIV at the end of 2 hours, he was put on a mechanical ventilator. Subsequently, the patient was put on HD and 2 L of ultrafiltrate fluid was drained. The patient was kept on a ventilator for 1 day and was extubated on postoperative day 2. He was stable on room air, maintaining 93% saturation, PR: 80; RR: 18; BP: 126/78. PE resolved on chest X-ray on postoperative day 4. (figure 4)
Post dialysis chest X-ray showing improved bilateral pulmonary oedema
Outcome and follow-up
The patient was discharged the day following admission (figure 5). He was advised to have HD three times a week and to have a regular check-up. He was followed up 6 months later. He is doing well, undergoing HD through the same AV fistula. He also got registered for renal transplant and is waiting for suitable donor.
Postoperative day 4 chest X-ray showing resolved pulmonary oedema.
Discussion
An arteriovenous fistula is a conduit for maintenance haemodilysis in patients with chronic kidney disease (CKD). AVF creation leads to an increase in circulatory volume. Cohen et al observed that patients with AVF have increased cardiac output (CO) and central venous pressure (CVP).4 Also, they observed that on compressing the AVF, the CO and CVP decreased. 4 Ewashima et al documented the changes on echocardiogram that were consistent with diastolic dysfunction in patients after AVF creation.5 A prospective comparison study found that AVF ligation reduced left ventricular hypertrophy in patients after kidney transplant.6 A retrospective cohort study found that patients on HD are more prone to acute exacerbations and new-onset heart failure, mainly with upper arm AVFs where PTFEs (Polytetrafluoroethylene) were used.7
FPE is an important cause of hospitalisation among patients with CKD on dialysis. Generally, it occurs in the early years of dialysis.8 It is seen nocturnally (after prolonged supine) in most cases and affects mainly men.9 Helle et al observed that bronchopneumonia, excessive interdialytic weight gain and inappropriate dry weight prescription were the most important causes of FPE. Ischaemic heart disease, diastolic dysfunction, dialysis discontinuation, irregular dialysis, hypertensive crisis and sepsis were among other causes.9 However, recent evidence suggests that intensive dialysis, 6–7 times/week, did not decrease the hospitalisation or mortality rates.8 The prevalence of FPE in patients with bilateral and unilateral renal arterial stenosis was 15.3% and 3.4%, respectively.8 Vélez-Martínez et al reported a similar case of FPE following balloon angioplasty after relief of HD graft stenosis.8
The exact timing of new-onset heart failure following AVF creation is not known; some studies have shown that it takes years, while others have shown as early as 6 weeks. But it can occur even earlier in patients with prior heart conditions.8 Turgutalp et al reported a case of a patient with acute heart failure 2 hours following angioplasty for central venous occlusion.10 She was kept on a ventilator and discharged after 2 days.
FPE is a medical emergency and should be managed immediately. The immediate goal of treatment is to stabilise the airway and haemodynamic condition of the patient. A detailed evaluation of the patient to reveal the precipitants of FPE should be undertaken after stabilising the patient. The key to managing FPE is to understand the pathophysiology and break the vicious cycle that underlies it.
Life-threatening acute PE occurs often due to redistribution of fluids. Pickering et al first described recurrent PE in hypertensive patients with bilateral renal artery stenosis.11 Patients with FPE generally progress rapidly and often require mechanical ventilation.11 Loop diuretics like furosemide and vasodilators like nitroprusside and nitroglycerine are used to decrease pulmonary congestion by reducing the preload.11 Minimal use of diuretics and optimal use of vasodilators is the goal of treatment in FPE. Patients with FPE who present with very high blood pressure often require multiple emergency antihypertensives such as carvedilol, labetalol, esmolol, etc. Other drugs like endothelin antagonists, inhaled NO and PDE-5 inhibitors have been found to be effective in managing pulmonary arterial hypertension and have been used in FPE.11 Additionally, immediate HD helps in removing some amount of fluid from the lungs.
These patients often develop repeat episodes of acute dyspnoea, so regular HD should be advised, and patients should be kept under regular follow-up at least for 1 month after the episode of FPE. Regular HD and control of blood pressure are the cornerstones of management for patients with recurrent episodes of FPE.11
Learning points
-
Irregular haemodialysis, cardiac dysfunction and uncontrolled hypertension are important risk factors for flash pulmonary oedema (PE).
-
Early identification of flash PE and quick implementation of a multidisciplinary team approach helped to break the vicious cycle of hypertensive crisis, myocardial dysfunction and impending ventilatory failure.
-
Regular haemodialysis and control of blood pressure are necessary in the prevention of flash PE.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors MMP and JA conceived the design. MMP was the first operating surgeon; the patient was evaluated, worked up and discussed by JA, BWG and BY. MMP, JA and BY were involved in radiological discussion and arriving at diagnosis. The patient was operated by MMP, JA, BWG and BY. MMP, JA and BWG collected the operating steps. Demography of the patient, clinical details and image editing was done by BWG, JA and BY, and further it was analysed by MMP. Manuscript was prepared by MMP, JA, BWG and BY. Editing of image was performed by BWG and JA. Case report was written, critically analysed, revised and uploaded by JA and MMP. Final approval of the case report is provided by MMP, JA, BWG and BY.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer